VceA and VceC, members of the VjbR regulon, were found out to be translocated into macrophages through theBrucellatype IV secretion system (De Jong et al.,2008). we further found that T effector cells derived from RB51SOD-immunized mice exhibited significantly higher cytotoxic T lymphocyte activity than T effector cells derived from RB51-immunized mice against virulentB. abortus-infected target cells. Meanwhile, the macrophage reactions to these two strains were also analyzed. Compared to RB51, RB51SOD cells experienced a lower survival rate in macrophages and induced lower levels of macrophage apoptosis and necrosis. The decreased survival of RB51SOD cells correlates with the higher level of sensitivity of RB51SOD, compared to RB51, to the bactericidal action of either Polymyxin B or sodium dodecyl sulfate (SDS). Furthermore, a physical damage to the outer membrane of RB51SOD was Empesertib observed by electron microscopy. Probably due to the physical damage, overexpressed Cu/Zn SOD in RB51SOD was found to be released into the bacterial cell tradition medium. Consequently, the stronger adaptive immunity induced by RB51SOD did not correlate with the low level of innate immunity induced by RB51SOD compared to RB51. This unique and apparently contradictory profile is likely associated with the variations in outer membrane integrity and Cu/Zn SOD launch. Keywords:Brucella abortusstrains RB51 and RB51SOD, Cu/Zn superoxide dismutase (Cu/Zn SOD), innate immunity, adaptive immunity, cytotoxic T lymphocyte (CTL), macrophage cell death, outer membrane integrity, protein release == Intro == Brucella abortusis a Gram-negative, facultative intracellular bacterium that causes brucellosis in humans and many animals (Corbel,1997). Brucellosis is one of the most common zoonotic diseases. It infects approximately 500, 000 humans annually worldwide. TheBrucellalack classical virulence factors, such as invasive proteases, exotoxins, pills, fimbriae, virulence plasmids, and lysogenic phages. The virulence ofBrucellarelies greatly on their ability to survive and replicate within the vacuolar phagocytic compartments of macrophages (Baldwin and Winter season,1994; Roop et al.,2009). As demonstrated in the mouse model, the ability of different varieties or strains ofBrucellato survive in macrophagesin vitrocorrelates with bacterial virulencein vivo. The virulence ofBrucellain vivoand their ability to survive in macrophagesin vitrocorrelates inversely with the innate resistance of the sponsor to brucellosis (Baldwin and Winter season,1994). The treatment of brucellosis remains hard and requires antibiotics that penetrate macrophages and may act in an acidic intracellular environment.Brucellalipopolysaccharide (LPS) is a virulence element that plays a critical part in Empesertib macrophageBrucellainteraction (Lapaque et al.,2005). Clean virulentBrucellastrains consist of an undamaged LPS, and are capable of inhibiting programmed cell death in infected human being and mouse macrophages (Gross et al.,2000; Tolomeo et al.,2003; He et al.,2006). RoughBrucellastrains lack O-antigen or produce extremely low levels of the antigen. Naturally occurring roughB. canisandB. ovisstrains are pathogenic in their favored hosts (Carmichael and Bruner,1968; Rahaley and Dennis,1984). Empesertib Some roughB. abortusstrains have been found to survive and replicate in macrophages (Pei and Ficht,2004). However, most rough strains ofBrucellaspp. are attenuated and cannot survive inside macrophages (Fernandez-Prada et al.,2003; Rittig et al.,2003; Pei and Ficht,2004; Chen and He,2009; Chen et al.,2011). Cattle brucellosis vaccine strain RB51 is definitely a rough live attenuatedB. abortusstrain derived from clean virulent strain 2308 (Schurig et al.,2002). A safe, effective human being brucellosis vaccine does not exist, but it is needed to increase general public health and biosafety. For rational vaccine design, it is important to understand the mechanism underlying protectiveBrucellaimmunity. Cell-mediated immunity (CMI) takes on an important part in adoptive protecting immunity to brucellosis. A T helper type 1 (Th1) immune response, indicated by IFN- production, is required for protectiveBrucellaimmunity (He et al.,2001,2002). Cytotoxic T lymphocyte (CTL) activity is critical for safety against brucellosis (Oliveira and Splitter,1995; He et al.,2001). RB51 vaccination of mice stimulates a strongBrucella-specific Th1 and CTL response (He et al.,2001). Recently, we reported that RB51, but not its parent wild type strain 2308, induced caspase-2-mediated apoptotic and necrotic murine Empesertib macrophage cell death (Chen and He,2009). It is suggested that programmed cell death of RB51-infected macrophages results in demonstration of RB51 antigens in apoptotic vesicles to dendritic cells (DCs) and further priming ofBrucella-specific T cells through a process called cross-priming (Yrlid and Wick,2000; Winau et al.,2005). The recombinant strain RB51SOD, which overexpressesBrucellaCu/Zn superoxide dismutase (SOD) in RB51 (Vemulapalli et KLF15 antibody al.,2000b), has been reported to induce a specific Th1 type immune response to Cu/Zn SOD and to confer enhanced safety against a virulentB. abortuschallenge (as compared to RB51; Vemulapalli et al.,2002).BrucellaCu/Zn SOD is a periplasmic protein, and an appropriate immune response to this protein confers safety againstB. abortuschallenge inside a mouse model (Vemulapalli et al.,2000b; He et al.,2002; Onate et al.,2003). Typically, BALB/c mice.